0000882104-19-000025.txt : 20190401
0000882104-19-000025.hdr.sgml : 20190401
20190401171215
ACCESSION NUMBER: 0000882104-19-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190328
FILED AS OF DATE: 20190401
DATE AS OF CHANGE: 20190401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARCIA PETER S
CENTRAL INDEX KEY: 0001188956
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 19721743
MAIL ADDRESS:
STREET 1: C/O BIOTIME INC
STREET 2: 1301 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
4
1
wf-form4_155415312035896.xml
FORM 4
X0306
4
2019-03-28
0
0000882104
PDL BIOPHARMA, INC.
PDLI
0001188956
GARCIA PETER S
C/O PDL BIOPHARMA, INC.
932 SOUTHWOOD BLVD.
INCLINE VILLAGE
NV
89451
0
1
0
0
Vice President, CFO
Stock Option (right to buy)
3.72
2019-03-28
4
A
0
628930
0
A
2029-03-28
Common stock
628930.0
628930
D
The stock options will vest as follows: (a) 25% of the shares subject to the option shall vest on the one year anniversary of January 1, 2019 and (b) 75% of the shares subject to the option shall vest on a monthly basis pro rata over the thirty-six (36) months following the one year anniversary of January 1, 2019, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient.
/s/ Nathan Kryszak, Attorney-in-Fact for Peter S. Garcia
2019-03-29